Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000529280 | SCV000660395 | uncertain significance | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2022-08-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 478627). This variant has not been reported in the literature in individuals affected with PLEC-related conditions. This variant is present in population databases (rs749212061, gnomAD 0.004%), including at least one homozygous and/or hemizygous individual. This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 4163 of the PLEC protein (p.Val4163Leu). |
Ce |
RCV003992330 | SCV004811375 | uncertain significance | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing |